Plan Name | BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN |
Plan identification number | 001 |
401k Plan Type | Defined Contribution Pension |
Plan Features/Benefits |
|
Company Name: | BIODELIVERY SCIENCES INTERNATIONAL, INC. |
Employer identification number (EIN): | 352089858 |
NAIC Classification: | 541700 |
Additional information about BIODELIVERY SCIENCES INTERNATIONAL, INC.
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 2015-08-31 |
Company Identification Number: | 0802284348 |
Legal Registered Office Address: |
100 TECHNOLOGY CENTER DR STE 300 STOUGHTON United States of America (USA) 02072 |
More information about BIODELIVERY SCIENCES INTERNATIONAL, INC.
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
001 | 2022-01-01 | ||||
001 | 2021-01-01 | ||||
001 | 2020-01-01 | ||||
001 | 2019-01-01 | ||||
001 | 2018-01-01 | ||||
001 | 2017-01-01 | ERNIE DEPAOLANTONIO | |||
001 | 2016-01-01 | ERNIE DEPAOLANTONIO | |||
001 | 2015-01-01 | ERNIE DEPAOLANTONIO | |||
001 | 2014-01-01 | ERNIE DEPAOLANTONIO | |||
001 | 2013-01-01 | JAMES MCNULTY | |||
001 | 2012-01-01 | IVAN SANABRIA | |||
001 | 2011-01-01 | IVAN SANABRIA | 2012-07-19 | ||
001 | 2010-01-01 | IVAN SANABRIA | 2011-07-08 | ||
001 | 2009-01-01 | KRISTY DUFFY SCHMIDT |
Measure | Date | Value |
---|---|---|
2022: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2022 401k membership | ||
Total participants, beginning-of-year | 2022-01-01 | 255 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 0 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 0 |
Total of all active and inactive participants | 2022-01-01 | 0 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 0 |
Total participants | 2022-01-01 | 0 |
2021: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2021 401k membership | ||
Total participants, beginning-of-year | 2021-01-01 | 236 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 187 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 68 |
Total of all active and inactive participants | 2021-01-01 | 255 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 0 |
Total participants | 2021-01-01 | 255 |
Number of participants with account balances | 2021-01-01 | 201 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
2020: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2020 401k membership | ||
Total participants, beginning-of-year | 2020-01-01 | 219 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 172 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 64 |
Total of all active and inactive participants | 2020-01-01 | 236 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 0 |
Total participants | 2020-01-01 | 236 |
Number of participants with account balances | 2020-01-01 | 193 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 0 |
2019: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2019 401k membership | ||
Total participants, beginning-of-year | 2019-01-01 | 191 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 174 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 45 |
Total of all active and inactive participants | 2019-01-01 | 219 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 0 |
Total participants | 2019-01-01 | 219 |
Number of participants with account balances | 2019-01-01 | 172 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 22 |
2018: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2018 401k membership | ||
Total participants, beginning-of-year | 2018-01-01 | 120 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 161 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 30 |
Total of all active and inactive participants | 2018-01-01 | 191 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 0 |
Total participants | 2018-01-01 | 191 |
Number of participants with account balances | 2018-01-01 | 146 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 14 |
2017: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2017 401k membership | ||
Total participants, beginning-of-year | 2017-01-01 | 97 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 92 |
Number of retired or separated participants receiving benefits | 2017-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 28 |
Total of all active and inactive participants | 2017-01-01 | 120 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 0 |
Total participants | 2017-01-01 | 120 |
Number of participants with account balances | 2017-01-01 | 94 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 21 |
2016: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2016 401k membership | ||
Total participants, beginning-of-year | 2016-01-01 | 52 |
Total number of active participants reported on line 7a of the Form 5500 | 2016-01-01 | 80 |
Number of retired or separated participants receiving benefits | 2016-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2016-01-01 | 17 |
Total of all active and inactive participants | 2016-01-01 | 97 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2016-01-01 | 0 |
Total participants | 2016-01-01 | 97 |
Number of participants with account balances | 2016-01-01 | 68 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2016-01-01 | 10 |
2015: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2015 401k membership | ||
Total participants, beginning-of-year | 2015-01-01 | 35 |
Total number of active participants reported on line 7a of the Form 5500 | 2015-01-01 | 41 |
Number of retired or separated participants receiving benefits | 2015-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2015-01-01 | 11 |
Total of all active and inactive participants | 2015-01-01 | 52 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2015-01-01 | 0 |
Total participants | 2015-01-01 | 52 |
Number of participants with account balances | 2015-01-01 | 42 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2015-01-01 | 2 |
2014: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2014 401k membership | ||
Total participants, beginning-of-year | 2014-01-01 | 32 |
Total number of active participants reported on line 7a of the Form 5500 | 2014-01-01 | 25 |
Number of retired or separated participants receiving benefits | 2014-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2014-01-01 | 10 |
Total of all active and inactive participants | 2014-01-01 | 35 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2014-01-01 | 0 |
Total participants | 2014-01-01 | 35 |
Number of participants with account balances | 2014-01-01 | 34 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2014-01-01 | 1 |
2013: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2013 401k membership | ||
Total participants, beginning-of-year | 2013-01-01 | 34 |
Total number of active participants reported on line 7a of the Form 5500 | 2013-01-01 | 22 |
Number of retired or separated participants receiving benefits | 2013-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2013-01-01 | 10 |
Total of all active and inactive participants | 2013-01-01 | 32 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2013-01-01 | 0 |
Total participants | 2013-01-01 | 32 |
Number of participants with account balances | 2013-01-01 | 30 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2013-01-01 | 0 |
2012: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2012 401k membership | ||
Total participants, beginning-of-year | 2012-01-01 | 32 |
Total number of active participants reported on line 7a of the Form 5500 | 2012-01-01 | 21 |
Number of retired or separated participants receiving benefits | 2012-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2012-01-01 | 13 |
Total of all active and inactive participants | 2012-01-01 | 34 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2012-01-01 | 0 |
Total participants | 2012-01-01 | 34 |
Number of participants with account balances | 2012-01-01 | 30 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2012-01-01 | 0 |
2009: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2009 401k membership | ||
Total participants, beginning-of-year | 2009-01-01 | 28 |
Total number of active participants reported on line 7a of the Form 5500 | 2009-01-01 | 17 |
Number of retired or separated participants receiving benefits | 2009-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2009-01-01 | 10 |
Total of all active and inactive participants | 2009-01-01 | 27 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2009-01-01 | 0 |
Total participants | 2009-01-01 | 27 |
Number of participants with account balances | 2009-01-01 | 27 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2009-01-01 | 2 |
Measure | Date | Value |
---|---|---|
2022 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2022 401k financial data | ||
Unrealized appreciation/depreciation of real estate assets | 2022-12-06 | $0 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-06 | $0 |
Total unrealized appreciation/depreciation of assets | 2022-12-06 | $0 |
Total transfer of assets to this plan | 2022-12-06 | $0 |
Total transfer of assets from this plan | 2022-12-06 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-06 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-06 | $0 |
Expenses. Interest paid | 2022-12-06 | $0 |
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2022-12-06 | $0 |
Total income from all sources (including contributions) | 2022-12-06 | $-554,411 |
Total loss/gain on sale of assets | 2022-12-06 | $0 |
Total of all expenses incurred | 2022-12-06 | $14,417,969 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-06 | $14,310,372 |
Expenses. Certain deemed distributions of participant loans | 2022-12-06 | $0 |
Value of total corrective distributions | 2022-12-06 | $65,679 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-06 | $1,457,927 |
Value of total assets at end of year | 2022-12-06 | $0 |
Value of total assets at beginning of year | 2022-12-06 | $14,972,380 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-06 | $41,918 |
Total income from rents | 2022-12-06 | $0 |
Total interest from all sources | 2022-12-06 | $3,819 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-06 | $54,281 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-06 | Yes |
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2022-12-06 | $0 |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-06 | $54,281 |
Assets. Real estate other than employer real property at end of year | 2022-12-06 | $0 |
Assets. Real estate other than employer real property at beginning of year | 2022-12-06 | $0 |
Administrative expenses professional fees incurred | 2022-12-06 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-06 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-06 | $0 |
Was this plan covered by a fidelity bond | 2022-12-06 | Yes |
Value of fidelity bond cover | 2022-12-06 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-06 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-06 | No |
Contributions received from participants | 2022-12-06 | $753,858 |
Participant contributions at end of year | 2022-12-06 | $0 |
Participant contributions at beginning of year | 2022-12-06 | $75,843 |
Participant contributions at end of year | 2022-12-06 | $0 |
Participant contributions at beginning of year | 2022-12-06 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2022-12-06 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2022-12-06 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-06 | $244,118 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-12-06 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-06 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-06 | $0 |
Assets. Loans (other than to participants) at end of year | 2022-12-06 | $0 |
Assets. Loans (other than to participants) at beginning of year | 2022-12-06 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-06 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-06 | $0 |
Other income not declared elsewhere | 2022-12-06 | $0 |
Administrative expenses (other) incurred | 2022-12-06 | $38,597 |
Liabilities. Value of operating payables at end of year | 2022-12-06 | $0 |
Liabilities. Value of operating payables at beginning of year | 2022-12-06 | $0 |
Total non interest bearing cash at end of year | 2022-12-06 | $0 |
Total non interest bearing cash at beginning of year | 2022-12-06 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-06 | No |
Income. Non cash contributions | 2022-12-06 | $0 |
Value of net income/loss | 2022-12-06 | $-14,972,380 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-06 | $0 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-06 | $14,972,380 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-06 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-06 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-06 | No |
Assets. partnership/joint venture interests at end of year | 2022-12-06 | $0 |
Assets. partnership/joint venture interests at beginning of year | 2022-12-06 | $0 |
Investment advisory and management fees | 2022-12-06 | $3,321 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-06 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-06 | $12,136,248 |
Value of interest in pooled separate accounts at end of year | 2022-12-06 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2022-12-06 | $0 |
Interest on participant loans | 2022-12-06 | $1,057 |
Income. Interest from loans (other than to participants) | 2022-12-06 | $0 |
Interest earned on other investments | 2022-12-06 | $0 |
Income. Interest from US Government securities | 2022-12-06 | $0 |
Income. Interest from corporate debt instruments | 2022-12-06 | $0 |
Value of interest in master investment trust accounts at end of year | 2022-12-06 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2022-12-06 | $0 |
Value of interest in common/collective trusts at end of year | 2022-12-06 | $0 |
Value of interest in common/collective trusts at beginning of year | 2022-12-06 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-06 | $0 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-06 | $2,760,289 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-06 | $2,760,289 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-06 | $2,762 |
Assets. Value of investments in 103.12 investment entities at end of year | 2022-12-06 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-12-06 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-06 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-06 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2022-12-06 | $0 |
Asset value of US Government securities at end of year | 2022-12-06 | $0 |
Asset value of US Government securities at beginning of year | 2022-12-06 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-06 | $-2,070,438 |
Net investment gain/loss from pooled separate accounts | 2022-12-06 | $0 |
Net investment gain or loss from common/collective trusts | 2022-12-06 | $0 |
Net gain/loss from 103.12 investment entities | 2022-12-06 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-06 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-06 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-06 | No |
Assets. Invements in employer securities at end of year | 2022-12-06 | $0 |
Assets. Invements in employer securities at beginning of year | 2022-12-06 | $0 |
Assets. Value of employer real property at end of year | 2022-12-06 | $0 |
Assets. Value of employer real property at beginning of year | 2022-12-06 | $0 |
Contributions received in cash from employer | 2022-12-06 | $459,951 |
Employer contributions (assets) at end of year | 2022-12-06 | $0 |
Employer contributions (assets) at beginning of year | 2022-12-06 | $0 |
Income. Dividends from preferred stock | 2022-12-06 | $0 |
Income. Dividends from common stock | 2022-12-06 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-06 | $14,310,372 |
Asset. Corporate debt instrument preferred debt at end of year | 2022-12-06 | $0 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-06 | $0 |
Asset. Corporate debt instrument debt (other) at end of year | 2022-12-06 | $0 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-06 | $0 |
Contract administrator fees | 2022-12-06 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-06 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-06 | $0 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-06 | $0 |
Liabilities. Value of benefit claims payable at end of year | 2022-12-06 | $0 |
Liabilities. Value of benefit claims payable at beginning of year | 2022-12-06 | $0 |
Assets. Value of buildings and other operty used in plan operation at end of year | 2022-12-06 | $0 |
Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-12-06 | $0 |
Did the plan have assets held for investment | 2022-12-06 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-06 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-06 | Yes |
Aggregate proceeds on sale of assets | 2022-12-06 | $0 |
Aggregate carrying amount (costs) on sale of assets | 2022-12-06 | $0 |
Liabilities. Value of acquisition indebtedness at end of year | 2022-12-06 | $0 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2022-12-06 | $0 |
Opinion of an independent qualified public accountant for this plan | 2022-12-06 | Unqualified |
Accountancy firm name | 2022-12-06 | CHERRY BEKEART |
Accountancy firm EIN | 2022-12-06 | 560574444 |
2021 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2021 401k financial data | ||
Unrealized appreciation/depreciation of real estate assets | 2021-12-31 | $0 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total transfer of assets to this plan | 2021-12-31 | $0 |
Total transfer of assets from this plan | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Expenses. Interest paid | 2021-12-31 | $0 |
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $4,834,014 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $2,569,534 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $2,531,362 |
Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $0 |
Value of total corrective distributions | 2021-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $3,203,999 |
Value of total assets at end of year | 2021-12-31 | $14,972,380 |
Value of total assets at beginning of year | 2021-12-31 | $12,707,900 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $38,172 |
Total income from rents | 2021-12-31 | $0 |
Total interest from all sources | 2021-12-31 | $5,409 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $677,262 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $677,262 |
Assets. Real estate other than employer real property at end of year | 2021-12-31 | $0 |
Assets. Real estate other than employer real property at beginning of year | 2021-12-31 | $0 |
Administrative expenses professional fees incurred | 2021-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $1,883,298 |
Participant contributions at end of year | 2021-12-31 | $75,843 |
Participant contributions at beginning of year | 2021-12-31 | $119,030 |
Participant contributions at end of year | 2021-12-31 | $0 |
Participant contributions at beginning of year | 2021-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $229,331 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2021-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $0 |
Assets. Loans (other than to participants) at end of year | 2021-12-31 | $0 |
Assets. Loans (other than to participants) at beginning of year | 2021-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $0 |
Other income not declared elsewhere | 2021-12-31 | $0 |
Administrative expenses (other) incurred | 2021-12-31 | $33,297 |
Liabilities. Value of operating payables at end of year | 2021-12-31 | $0 |
Liabilities. Value of operating payables at beginning of year | 2021-12-31 | $0 |
Total non interest bearing cash at end of year | 2021-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2021-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Income. Non cash contributions | 2021-12-31 | $0 |
Value of net income/loss | 2021-12-31 | $2,264,480 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $14,972,380 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $12,707,900 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2021-12-31 | $0 |
Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $0 |
Investment advisory and management fees | 2021-12-31 | $4,875 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $12,136,248 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $10,254,791 |
Value of interest in pooled separate accounts at end of year | 2021-12-31 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $0 |
Interest on participant loans | 2021-12-31 | $5,144 |
Income. Interest from loans (other than to participants) | 2021-12-31 | $0 |
Interest earned on other investments | 2021-12-31 | $0 |
Income. Interest from US Government securities | 2021-12-31 | $0 |
Income. Interest from corporate debt instruments | 2021-12-31 | $0 |
Value of interest in master investment trust accounts at end of year | 2021-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2021-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2021-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $2,760,289 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $2,334,079 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $2,334,079 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $265 |
Assets. Value of investments in 103.12 investment entities at end of year | 2021-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2021-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2021-12-31 | $0 |
Asset value of US Government securities at end of year | 2021-12-31 | $0 |
Asset value of US Government securities at beginning of year | 2021-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $947,344 |
Net investment gain/loss from pooled separate accounts | 2021-12-31 | $0 |
Net investment gain or loss from common/collective trusts | 2021-12-31 | $0 |
Net gain/loss from 103.12 investment entities | 2021-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Assets. Invements in employer securities at end of year | 2021-12-31 | $0 |
Assets. Invements in employer securities at beginning of year | 2021-12-31 | $0 |
Assets. Value of employer real property at end of year | 2021-12-31 | $0 |
Assets. Value of employer real property at beginning of year | 2021-12-31 | $0 |
Contributions received in cash from employer | 2021-12-31 | $1,091,370 |
Employer contributions (assets) at end of year | 2021-12-31 | $0 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $0 |
Income. Dividends from preferred stock | 2021-12-31 | $0 |
Income. Dividends from common stock | 2021-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $2,531,362 |
Asset. Corporate debt instrument preferred debt at end of year | 2021-12-31 | $0 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2021-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $0 |
Contract administrator fees | 2021-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $0 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
Liabilities. Value of benefit claims payable at end of year | 2021-12-31 | $0 |
Liabilities. Value of benefit claims payable at beginning of year | 2021-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at end of year | 2021-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at beginning of year | 2021-12-31 | $0 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Aggregate proceeds on sale of assets | 2021-12-31 | $0 |
Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at end of year | 2021-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2021-12-31 | $0 |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Disclaimer |
Accountancy firm name | 2021-12-31 | CHERRY BEKEART |
Accountancy firm EIN | 2021-12-31 | 560574444 |
2020 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2020 401k financial data | ||
Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $0 |
Total transfer of assets from this plan | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Expenses. Interest paid | 2020-12-31 | $0 |
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $4,939,672 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $1,833,063 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $1,784,424 |
Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $18,761 |
Value of total corrective distributions | 2020-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $3,433,148 |
Value of total assets at end of year | 2020-12-31 | $12,707,900 |
Value of total assets at beginning of year | 2020-12-31 | $9,601,291 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $29,878 |
Total income from rents | 2020-12-31 | $0 |
Total interest from all sources | 2020-12-31 | $13,380 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $313,503 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $313,503 |
Assets. Real estate other than employer real property at end of year | 2020-12-31 | $0 |
Assets. Real estate other than employer real property at beginning of year | 2020-12-31 | $0 |
Administrative expenses professional fees incurred | 2020-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $1,863,541 |
Participant contributions at end of year | 2020-12-31 | $119,030 |
Participant contributions at beginning of year | 2020-12-31 | $129,781 |
Participant contributions at end of year | 2020-12-31 | $0 |
Participant contributions at beginning of year | 2020-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $488,248 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
Assets. Loans (other than to participants) at end of year | 2020-12-31 | $0 |
Assets. Loans (other than to participants) at beginning of year | 2020-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
Other income not declared elsewhere | 2020-12-31 | $0 |
Administrative expenses (other) incurred | 2020-12-31 | $24,735 |
Liabilities. Value of operating payables at end of year | 2020-12-31 | $0 |
Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
Total non interest bearing cash at end of year | 2020-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Income. Non cash contributions | 2020-12-31 | $0 |
Value of net income/loss | 2020-12-31 | $3,106,609 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $12,707,900 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $9,601,291 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2020-12-31 | $0 |
Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $0 |
Investment advisory and management fees | 2020-12-31 | $5,143 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $10,254,791 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $7,673,545 |
Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
Interest on participant loans | 2020-12-31 | $8,038 |
Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
Interest earned on other investments | 2020-12-31 | $0 |
Income. Interest from US Government securities | 2020-12-31 | $0 |
Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
Value of interest in master investment trust accounts at end of year | 2020-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2020-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $2,334,079 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $1,797,965 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $1,797,965 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $5,342 |
Assets. Value of investments in 103.12 investment entities at end of year | 2020-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2020-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
Asset value of US Government securities at end of year | 2020-12-31 | $0 |
Asset value of US Government securities at beginning of year | 2020-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $1,179,641 |
Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
Net investment gain or loss from common/collective trusts | 2020-12-31 | $0 |
Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Assets. Invements in employer securities at end of year | 2020-12-31 | $0 |
Assets. Invements in employer securities at beginning of year | 2020-12-31 | $0 |
Assets. Value of employer real property at end of year | 2020-12-31 | $0 |
Assets. Value of employer real property at beginning of year | 2020-12-31 | $0 |
Contributions received in cash from employer | 2020-12-31 | $1,081,359 |
Employer contributions (assets) at end of year | 2020-12-31 | $0 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
Income. Dividends from preferred stock | 2020-12-31 | $0 |
Income. Dividends from common stock | 2020-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $1,784,424 |
Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $0 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2020-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $0 |
Contract administrator fees | 2020-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $0 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
Liabilities. Value of benefit claims payable at end of year | 2020-12-31 | $0 |
Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at end of year | 2020-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at beginning of year | 2020-12-31 | $0 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Aggregate proceeds on sale of assets | 2020-12-31 | $0 |
Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at end of year | 2020-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | CHERRY BEKEART |
Accountancy firm EIN | 2020-12-31 | 560574444 |
2019 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2019 401k financial data | ||
Unrealized appreciation/depreciation of real estate assets | 2019-12-31 | $0 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total transfer of assets to this plan | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Expenses. Interest paid | 2019-12-31 | $0 |
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $4,100,065 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $810,387 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $786,784 |
Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
Value of total corrective distributions | 2019-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,687,844 |
Value of total assets at end of year | 2019-12-31 | $9,601,291 |
Value of total assets at beginning of year | 2019-12-31 | $6,311,613 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $23,603 |
Total income from rents | 2019-12-31 | $0 |
Total interest from all sources | 2019-12-31 | $35,811 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $282,776 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $282,776 |
Assets. Real estate other than employer real property at end of year | 2019-12-31 | $0 |
Assets. Real estate other than employer real property at beginning of year | 2019-12-31 | $0 |
Administrative expenses professional fees incurred | 2019-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $1,548,290 |
Participant contributions at end of year | 2019-12-31 | $129,781 |
Participant contributions at beginning of year | 2019-12-31 | $113,031 |
Participant contributions at end of year | 2019-12-31 | $0 |
Participant contributions at beginning of year | 2019-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $311,790 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $0 |
Assets. Loans (other than to participants) at end of year | 2019-12-31 | $0 |
Assets. Loans (other than to participants) at beginning of year | 2019-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $0 |
Other income not declared elsewhere | 2019-12-31 | $0 |
Administrative expenses (other) incurred | 2019-12-31 | $19,237 |
Liabilities. Value of operating payables at end of year | 2019-12-31 | $0 |
Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $0 |
Total non interest bearing cash at end of year | 2019-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Income. Non cash contributions | 2019-12-31 | $0 |
Value of net income/loss | 2019-12-31 | $3,289,678 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $9,601,291 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $6,311,613 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2019-12-31 | $0 |
Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $0 |
Investment advisory and management fees | 2019-12-31 | $4,366 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $7,673,545 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $5,111,167 |
Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
Interest on participant loans | 2019-12-31 | $7,801 |
Income. Interest from loans (other than to participants) | 2019-12-31 | $0 |
Interest earned on other investments | 2019-12-31 | $0 |
Income. Interest from US Government securities | 2019-12-31 | $0 |
Income. Interest from corporate debt instruments | 2019-12-31 | $0 |
Value of interest in master investment trust accounts at end of year | 2019-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $1,797,965 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $1,087,415 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $1,087,415 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $28,010 |
Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2019-12-31 | $0 |
Asset value of US Government securities at end of year | 2019-12-31 | $0 |
Asset value of US Government securities at beginning of year | 2019-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $1,093,634 |
Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $0 |
Net gain/loss from 103.12 investment entities | 2019-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Assets. Invements in employer securities at end of year | 2019-12-31 | $0 |
Assets. Invements in employer securities at beginning of year | 2019-12-31 | $0 |
Assets. Value of employer real property at end of year | 2019-12-31 | $0 |
Assets. Value of employer real property at beginning of year | 2019-12-31 | $0 |
Contributions received in cash from employer | 2019-12-31 | $827,764 |
Employer contributions (assets) at end of year | 2019-12-31 | $0 |
Employer contributions (assets) at beginning of year | 2019-12-31 | $0 |
Income. Dividends from preferred stock | 2019-12-31 | $0 |
Income. Dividends from common stock | 2019-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $786,784 |
Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $0 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $0 |
Contract administrator fees | 2019-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $0 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
Liabilities. Value of benefit claims payable at end of year | 2019-12-31 | $0 |
Liabilities. Value of benefit claims payable at beginning of year | 2019-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at end of year | 2019-12-31 | $0 |
Assets. Value of buildings and other operty used in plan operation at beginning of year | 2019-12-31 | $0 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Aggregate proceeds on sale of assets | 2019-12-31 | $0 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $0 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | CHERRY BEKEART |
Accountancy firm EIN | 2019-12-31 | 560574444 |
2018 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2018 401k financial data | ||
Transfers to/from the plan | 2018-12-31 | $0 |
Total plan liabilities at end of year | 2018-12-31 | $0 |
Total plan liabilities at beginning of year | 2018-12-31 | $0 |
Total income from all sources | 2018-12-31 | $1,902,582 |
Expenses. Total of all expenses incurred | 2018-12-31 | $2,044,397 |
Benefits paid (including direct rollovers) | 2018-12-31 | $2,024,029 |
Total plan assets at end of year | 2018-12-31 | $6,311,613 |
Total plan assets at beginning of year | 2018-12-31 | $6,453,428 |
Value of fidelity bond covering the plan | 2018-12-31 | $500,000 |
Total contributions received or receivable from participants | 2018-12-31 | $1,257,615 |
Expenses. Other expenses not covered elsewhere | 2018-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2018-12-31 | $356,670 |
Other income received | 2018-12-31 | $-392,118 |
Noncash contributions received | 2018-12-31 | $0 |
Net income (gross income less expenses) | 2018-12-31 | $-141,815 |
Net plan assets at end of year (total assets less liabilities) | 2018-12-31 | $6,311,613 |
Net plan assets at beginning of year (total assets less liabilities) | 2018-12-31 | $6,453,428 |
Assets. Value of participant loans | 2018-12-31 | $113,031 |
Total contributions received or receivable from employer(s) | 2018-12-31 | $680,415 |
Value of certain deemed distributions of participant loans | 2018-12-31 | $0 |
Value of corrective distributions | 2018-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2018-12-31 | $20,368 |
2017 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2017 401k financial data | ||
Transfers to/from the plan | 2017-12-31 | $0 |
Total plan liabilities at end of year | 2017-12-31 | $0 |
Total plan liabilities at beginning of year | 2017-12-31 | $0 |
Total income from all sources | 2017-12-31 | $2,471,373 |
Expenses. Total of all expenses incurred | 2017-12-31 | $653,863 |
Benefits paid (including direct rollovers) | 2017-12-31 | $639,949 |
Total plan assets at end of year | 2017-12-31 | $6,453,428 |
Total plan assets at beginning of year | 2017-12-31 | $4,635,918 |
Value of fidelity bond covering the plan | 2017-12-31 | $500,000 |
Assets. Value of tangible personal property | 2017-12-31 | $0 |
Total contributions received or receivable from participants | 2017-12-31 | $875,530 |
Assets. Value of loans (other than to participants) | 2017-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2017-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2017-12-31 | $356,669 |
Other income received | 2017-12-31 | $793,171 |
Noncash contributions received | 2017-12-31 | $0 |
Net income (gross income less expenses) | 2017-12-31 | $1,817,510 |
Net plan assets at end of year (total assets less liabilities) | 2017-12-31 | $6,453,428 |
Net plan assets at beginning of year (total assets less liabilities) | 2017-12-31 | $4,635,918 |
Assets. Value of participant loans | 2017-12-31 | $114,031 |
Assets. Value of assets in partnership/joint-venture interests | 2017-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2017-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2017-12-31 | $0 |
Assets. Value of employer securities | 2017-12-31 | $0 |
Assets. Value of employer real property | 2017-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2017-12-31 | $446,003 |
Value of certain deemed distributions of participant loans | 2017-12-31 | $0 |
Value of corrective distributions | 2017-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2017-12-31 | $13,914 |
2016 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2016 401k financial data | ||
Transfers to/from the plan | 2016-12-31 | $0 |
Total plan liabilities at end of year | 2016-12-31 | $0 |
Total plan liabilities at beginning of year | 2016-12-31 | $0 |
Total income from all sources | 2016-12-31 | $1,419,275 |
Expenses. Total of all expenses incurred | 2016-12-31 | $672,390 |
Benefits paid (including direct rollovers) | 2016-12-31 | $660,276 |
Total plan assets at end of year | 2016-12-31 | $4,635,918 |
Total plan assets at beginning of year | 2016-12-31 | $3,889,033 |
Value of fidelity bond covering the plan | 2016-12-31 | $400,000 |
Total contributions received or receivable from participants | 2016-12-31 | $631,958 |
Expenses. Other expenses not covered elsewhere | 2016-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2016-12-31 | $136,287 |
Other income received | 2016-12-31 | $351,323 |
Noncash contributions received | 2016-12-31 | $0 |
Net income (gross income less expenses) | 2016-12-31 | $746,885 |
Net plan assets at end of year (total assets less liabilities) | 2016-12-31 | $4,635,918 |
Net plan assets at beginning of year (total assets less liabilities) | 2016-12-31 | $3,889,033 |
Assets. Value of participant loans | 2016-12-31 | $37,384 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2016-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2016-12-31 | $299,707 |
Value of certain deemed distributions of participant loans | 2016-12-31 | $0 |
Value of corrective distributions | 2016-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2016-12-31 | $12,114 |
2015 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2015 401k financial data | ||
Transfers to/from the plan | 2015-12-31 | $0 |
Total plan liabilities at end of year | 2015-12-31 | $0 |
Total plan liabilities at beginning of year | 2015-12-31 | $0 |
Total income from all sources | 2015-12-31 | $734,347 |
Expenses. Total of all expenses incurred | 2015-12-31 | $754,614 |
Benefits paid (including direct rollovers) | 2015-12-31 | $743,409 |
Total plan assets at end of year | 2015-12-31 | $3,889,033 |
Total plan assets at beginning of year | 2015-12-31 | $3,909,300 |
Value of fidelity bond covering the plan | 2015-12-31 | $400,000 |
Total contributions received or receivable from participants | 2015-12-31 | $441,671 |
Expenses. Other expenses not covered elsewhere | 2015-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2015-12-31 | $121,361 |
Other income received | 2015-12-31 | $-41,809 |
Noncash contributions received | 2015-12-31 | $0 |
Net income (gross income less expenses) | 2015-12-31 | $-20,267 |
Net plan assets at end of year (total assets less liabilities) | 2015-12-31 | $3,889,033 |
Net plan assets at beginning of year (total assets less liabilities) | 2015-12-31 | $3,909,300 |
Assets. Value of participant loans | 2015-12-31 | $41,328 |
Total contributions received or receivable from employer(s) | 2015-12-31 | $213,124 |
Value of certain deemed distributions of participant loans | 2015-12-31 | $0 |
Value of corrective distributions | 2015-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2015-12-31 | $11,205 |
2014 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2014 401k financial data | ||
Transfers to/from the plan | 2014-12-31 | $0 |
Total plan liabilities at end of year | 2014-12-31 | $0 |
Total plan liabilities at beginning of year | 2014-12-31 | $0 |
Total income from all sources | 2014-12-31 | $832,915 |
Expenses. Total of all expenses incurred | 2014-12-31 | $100,226 |
Benefits paid (including direct rollovers) | 2014-12-31 | $89,766 |
Total plan assets at end of year | 2014-12-31 | $3,909,300 |
Total plan assets at beginning of year | 2014-12-31 | $3,176,611 |
Value of fidelity bond covering the plan | 2014-12-31 | $250,000 |
Total contributions received or receivable from participants | 2014-12-31 | $418,611 |
Expenses. Other expenses not covered elsewhere | 2014-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2014-12-31 | $0 |
Other income received | 2014-12-31 | $219,543 |
Noncash contributions received | 2014-12-31 | $0 |
Net income (gross income less expenses) | 2014-12-31 | $732,689 |
Net plan assets at end of year (total assets less liabilities) | 2014-12-31 | $3,909,300 |
Net plan assets at beginning of year (total assets less liabilities) | 2014-12-31 | $3,176,611 |
Assets. Value of participant loans | 2014-12-31 | $4,742 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2014-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2014-12-31 | $194,761 |
Value of certain deemed distributions of participant loans | 2014-12-31 | $0 |
Value of corrective distributions | 2014-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2014-12-31 | $10,460 |
2013 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2013 401k financial data | ||
Transfers to/from the plan | 2013-12-31 | $0 |
Total plan liabilities at end of year | 2013-12-31 | $0 |
Total income from all sources | 2013-12-31 | $921,823 |
Expenses. Total of all expenses incurred | 2013-12-31 | $325,291 |
Benefits paid (including direct rollovers) | 2013-12-31 | $317,173 |
Total plan assets at end of year | 2013-12-31 | $3,176,611 |
Total plan assets at beginning of year | 2013-12-31 | $2,580,079 |
Value of fidelity bond covering the plan | 2013-12-31 | $250,000 |
Total contributions received or receivable from participants | 2013-12-31 | $311,516 |
Expenses. Other expenses not covered elsewhere | 2013-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2013-12-31 | $0 |
Other income received | 2013-12-31 | $436,790 |
Noncash contributions received | 2013-12-31 | $0 |
Net income (gross income less expenses) | 2013-12-31 | $596,532 |
Net plan assets at end of year (total assets less liabilities) | 2013-12-31 | $3,176,611 |
Net plan assets at beginning of year (total assets less liabilities) | 2013-12-31 | $2,580,079 |
Assets. Value of participant loans | 2013-12-31 | $5,318 |
Total contributions received or receivable from employer(s) | 2013-12-31 | $173,517 |
Value of certain deemed distributions of participant loans | 2013-12-31 | $0 |
Value of corrective distributions | 2013-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2013-12-31 | $8,118 |
2012 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2012 401k financial data | ||
Total income from all sources | 2012-12-31 | $631,738 |
Expenses. Total of all expenses incurred | 2012-12-31 | $128,322 |
Benefits paid (including direct rollovers) | 2012-12-31 | $127,549 |
Total plan assets at end of year | 2012-12-31 | $2,580,079 |
Total plan assets at beginning of year | 2012-12-31 | $2,076,663 |
Value of fidelity bond covering the plan | 2012-12-31 | $250,000 |
Total contributions received or receivable from participants | 2012-12-31 | $253,285 |
Other income received | 2012-12-31 | $252,882 |
Net income (gross income less expenses) | 2012-12-31 | $503,416 |
Net plan assets at end of year (total assets less liabilities) | 2012-12-31 | $2,580,079 |
Net plan assets at beginning of year (total assets less liabilities) | 2012-12-31 | $2,076,663 |
Assets. Value of participant loans | 2012-12-31 | $5,842 |
Total contributions received or receivable from employer(s) | 2012-12-31 | $125,571 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2012-12-31 | $773 |
2009 : BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2009 401k financial data | ||
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |
2022: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | Submission has been amended | Yes |
2022-01-01 | This submission is the final filing | Yes |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | Yes |
2022-01-01 | Plan is a collectively bargained plan | No |
2022-01-01 | Plan funding arrangement – Trust | Yes |
2022-01-01 | Plan benefit arrangement - Trust | Yes |
2021: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |
2019: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2019-01-01 | Plan funding arrangement – Trust | Yes |
2019-01-01 | Plan benefit arrangement - Trust | Yes |
2018: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2018-01-01 | Plan funding arrangement – Trust | Yes |
2018-01-01 | Plan benefit arrangement - Trust | Yes |
2017: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | Single employer plan |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2017-01-01 | Plan funding arrangement – Trust | Yes |
2017-01-01 | Plan benefit arrangement - Trust | Yes |
2016: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2016 form 5500 responses | ||
2016-01-01 | Type of plan entity | Single employer plan |
2016-01-01 | Submission has been amended | No |
2016-01-01 | This submission is the final filing | No |
2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2016-01-01 | Plan is a collectively bargained plan | No |
2016-01-01 | Plan funding arrangement – Trust | Yes |
2016-01-01 | Plan benefit arrangement - Trust | Yes |
2015: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2015 form 5500 responses | ||
2015-01-01 | Type of plan entity | Single employer plan |
2015-01-01 | Submission has been amended | No |
2015-01-01 | This submission is the final filing | No |
2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2015-01-01 | Plan is a collectively bargained plan | No |
2015-01-01 | Plan funding arrangement – Trust | Yes |
2015-01-01 | Plan benefit arrangement - Trust | Yes |
2014: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2014 form 5500 responses | ||
2014-01-01 | Type of plan entity | Single employer plan |
2014-01-01 | Submission has been amended | No |
2014-01-01 | This submission is the final filing | No |
2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2014-01-01 | Plan is a collectively bargained plan | No |
2014-01-01 | Plan funding arrangement – Trust | Yes |
2014-01-01 | Plan benefit arrangement - Trust | Yes |
2013: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2013 form 5500 responses | ||
2013-01-01 | Type of plan entity | Single employer plan |
2013-01-01 | Submission has been amended | No |
2013-01-01 | This submission is the final filing | No |
2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2013-01-01 | Plan is a collectively bargained plan | No |
2013-01-01 | Plan funding arrangement – Trust | Yes |
2013-01-01 | Plan benefit arrangement - Trust | Yes |
2012: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2012 form 5500 responses | ||
2012-01-01 | Type of plan entity | Single employer plan |
2012-01-01 | Submission has been amended | No |
2012-01-01 | This submission is the final filing | No |
2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2012-01-01 | Plan funding arrangement – Trust | Yes |
2012-01-01 | Plan benefit arrangement - Trust | Yes |
2009: BIODELIVERY SCIENCES INTERNATIONAL, INC. 401(K) PLAN 2009 form 5500 responses | ||
2009-01-01 | Type of plan entity | Single employer plan |
2009-01-01 | Submission has been amended | No |
2009-01-01 | This submission is the final filing | No |
2009-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2009-01-01 | Plan is a collectively bargained plan | No |
2009-01-01 | Plan funding arrangement – Trust | Yes |
2009-01-01 | Plan benefit arrangement - Trust | Yes |